Breaking News
September 20, 2018 - AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
September 20, 2018 - Characterization of pregnancy microbiome reveals variations in bacterial diversity
September 20, 2018 - New guidance for treatment of bone loss in hematologic stem cell transplant Recipients
September 20, 2018 - Experts to present research on prevention, management of dysphagia at international conference
September 20, 2018 - New study focuses on two-way gene switches controlling gene activity
September 20, 2018 - Zika virus could become a weapon against brain cancer
September 20, 2018 - Home-based video game exercises can reduce chronic low back pain in older people, study finds
September 20, 2018 - Investigators find that bile acids reduce cocaine reward
September 20, 2018 - Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance
September 20, 2018 - Health care companies’ data could enable more accurate flu season forecasts
September 20, 2018 - Geroscience takes center stage in Journal of the American Medical Association
September 20, 2018 - Ambient Particulate Matter Linked to Emergency Asthma Care
September 20, 2018 - Patient satisfaction with plastic surgery—it’s the surgeon, not the practice
September 20, 2018 - Medicine is a team sport – and that’s exactly how it should be
September 20, 2018 - Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space
September 20, 2018 - Novel micro-platform reveals never-before-seen behaviors of cancer cells
September 20, 2018 - PAREXEL partners with Datavant to enhance clinical study design and generate real-world evidence
September 20, 2018 - Robert Koch Institute publishes new data on allergies, mental health problems, and accident injuries
September 20, 2018 - Study finds higher readmission rates in for-profit hospitals
September 20, 2018 - Encouraging youth to do strength-based exercises could help tackle child obesity
September 20, 2018 - Sleep apnea, congenital heart disease in hospitalized infants strongly associated with death
September 20, 2018 - Researchers find way to map mysterious content of non-coding RNA
September 20, 2018 - Air Pollutants Reach Placenta, Might Harm Fetus: Study
September 20, 2018 - Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants
September 20, 2018 - My relative has cancer, should I worry? Encouraging cascade genetic testing
September 20, 2018 - Investigators determine specific treatable traits that can predict future asthma attacks
September 20, 2018 - More doctor visits can lower risk of suicide attempts in fibromyalgia patients
September 20, 2018 - Computer avatars play role in diagnosis of dementia
September 20, 2018 - Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer
September 20, 2018 - ASPREE trial explores whether low dose aspirin can prolong good health in elderly people
September 20, 2018 - ATS publishes new guideline focused on weight loss strategies for sleep apnea patients
September 20, 2018 - The Current issue of “The view from here” is concerned with Drug Delivery
September 19, 2018 - Sleep apnea could favour tumor growth at young ages
September 19, 2018 - Stealth vaping fad hidden from parents, teachers
September 19, 2018 - Witnessing school violence linked to later risk of psycho-social and academic impairment
September 19, 2018 - Common household cleaners could make children overweight by changing gut microbiota
September 19, 2018 - Salk research in yeast leads to serendipitous finding about hypomyelinating leukodystrophy
September 19, 2018 - Study: Overweight or obese women may have increased risk of urinary incontinence
September 19, 2018 - Study shows how cellular waste disposal processes also promote inflammation
September 19, 2018 - New multidisciplinary microsurgery microscope, PROVIDO, introduced by Leica
September 19, 2018 - Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting
September 19, 2018 - Decisions recruiting gut feelings seen as reflection of true self, more assuredly held, study says
September 19, 2018 - How AI can improve end-of-life care
September 19, 2018 - UNIST and Ulsan initiate research collaboration to develop human organs-on-chips
September 19, 2018 - Study highlights key role of migrating shoals of fish in sustaining deep-ocean microorganisms
September 19, 2018 - Disagreeable individuals can benefit most from behaving more compassionately, finds study
September 19, 2018 - Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
September 19, 2018 - Neuroplasticity is increased but dysregulated in the aging brain, study finds
September 19, 2018 - Suicide: A public health crisis
September 19, 2018 - Infants using popular anti-reflux medicines are not at increased risk of lung infections
September 19, 2018 - Stanford team will participate in NIH-funded study of tobacco policies | News Center
September 19, 2018 - Women with high levels of anti-Müllerian hormone more likely to develop breast cancer
September 19, 2018 - Researchers use larval zebrafish model to reveal role of locus coeruleus in anesthesia
September 19, 2018 - Effects of prematurity found to be more severe for the brains of males than females
September 19, 2018 - NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease
September 19, 2018 - NUS researchers develop new device for quick and accurate screening of diseases
September 19, 2018 - Leading nutritionist explains about different types of iron in oral supplements
September 19, 2018 - New Crest Gum & Enamel Repair toothpaste may boost enamel repair and reverse gingivitis
September 19, 2018 - Analysis does not find any safety concerns of bivalent HPV vaccine
September 19, 2018 - Many Older Adults Transition to Long-Term Benzodiazepine Use
September 19, 2018 - Caregiving – resources – older adults: MedlinePlus Medical Encyclopedia
September 19, 2018 - Research shows that cystic fibrosis impacts growth in the womb
September 19, 2018 - Study shows how head, neck positioning affects concussion risk | News Center
September 19, 2018 - Antioxidant in green tea helps sneak therapeutic RNAs into cells
September 19, 2018 - Excess pregnancy weight gain affects cardiometabolic risk in offspring
September 19, 2018 - Penn researchers find common thread linking almost all TNR expansion diseases
September 19, 2018 - Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma
September 19, 2018 - Researchers use CRISPR screen to reveal new targets in squamous cell carcinomas
September 19, 2018 - UGR to coordinate the European H2020 project focused on Smart Personalized Nutrition
September 19, 2018 - Mumps Spread Quickly at Texas Cheerleading Meets: Study
September 19, 2018 - Addressing child stunting in Pakistan is critical
September 19, 2018 - Innovative system makes hospitals, clinics accessible for people with visual impairments
September 19, 2018 - CXCL14 protein is secreted by brown adipose tissue and has beneficial effects in metabolic diseases
September 19, 2018 - Air pollution increases risk of dementia
September 19, 2018 - Inequality issues persist even under new U.S. kidney transplant allocation system
September 19, 2018 - New study reveals mechanisms that lead to cognitive decline in Type 2 diabetes
September 19, 2018 - FDA launches new comprehensive effort to educate kids about dangers of e-cigarettes
September 19, 2018 - Study reveals mechanism underlying plants’ ability to signal defense
September 19, 2018 - Researchers harness Zika virus vaccine under development to target glioblastoma
September 19, 2018 - Novel deep learning drug discovery platform gets £1 million innovation boost
Study: Insufficient Oversight on Modifying FDA-Approved Devices

Study: Insufficient Oversight on Modifying FDA-Approved Devices

image_pdfDownload PDFimage_print

Action Points

  • Manufacturers of dermatologic devices are increasingly gaining approval for device modifications via post-initial approval pathways requiring minimal supporting clinical data, which could influence device effectiveness and safety.
  • Note that these data suggest that greater transparency and higher standards of review may improve inconsistencies in usage of pathways for device approvals, and this will allow better assessment of the safety of device modifications.

Dermatologic device makers often slip substantial product changes through FDA clearance by taking advantage of loose premarket approval (PMA) supplement applications, researchers said.

A search through the FDA online PMA database showed that for the 27 Class III dermatologic devices approved between 1980 and 2016 through the PMA pathway, 562 PMA supplements were green-lighted. On the whole, device makers ramped up their use of these supplemental applications over time: in 1980-1989, supplements were approved at 3.7 per year, whereas the 2006-2015 period saw 36.7 supplements approved per year (an 891.9% increase), according to the study published online in JAMA Dermatology.

“This indicates a higher rate of supplements per device-year in dermatology than other reported specialties, including orthopedics, otolaryngology, and cardiology,” said investigators led by Harib Ezaldein, MD, of University Hospitals Cleveland Medical Center. The 27 dermatologic devices that had approved changes were 14 injectables, 11 photodynamic therapies, one dermal replacement matrix, and one diagnostic imaging instrument.

The worry is that dermatology device changes may not be sufficiently backed by clinical data in many cases, the team suggested, noting that the 30-day supplement track that does not require clinical data (meant only for adjustments to a device’s manufacturing process) accounted for 42.5% of supplemental PMA approvals.

Meanwhile, it appeared that the rigorous panel-track pathway was much less popular, coming in at just 2.8% of PMA supplement approvals. This track requires clinical data and is intended for significant changes such as those in device design or performance, or a new indication for use.

It is therefore problematic that another track, the 180-day process, was used for 41.7% of label indication changes instead of the aforementioned comprehensive panel track requiring clinical data and a formal review process. “As manufacturers make increasing use of supplemental applications, minor device changes may occur without supporting clinical data, which could pose a safety risk to patients,” Ezaldein and colleagues wrote.

Indeed, safety issues came up eventually in many cases, with 14.8% of dermatologic devices undergoing low-risk recalls (Class II or III) and 37.0% voluntarily withdrawn by the manufacturer. For example, both injectable products from Merz were recalled after undergoing 135- and 30-day applications).

“The current regulatory environment does not provide sufficient information necessary for dermatologists to make informed clinical judgment regarding potential device problems,” the researchers emphasized. “There is a dearth of FDA review memos in dermatology, which are normally published to disclose information about modifications. Increasing disclosure about device modifications across all supplementary pathways may promote more reliable safety in Class III dermatologic devices.”

Caveats to the study include the exclusion of devices approved through the cheaper and less robust 510(k) pathway, the authors acknowledged.

Nonetheless, they suggested that to make devices safer for patients, an advisory board tasked with reviewing a product for clinically significant device drift after a defined number of years or PMA supplement applications should be created.

Employees of the FDA responded in an accompanying editorial that the agency is in fact making efforts to improve how it assesses medical device safety: In building the National Evaluation System for Health Technology (NEST), it “will link and synthesize data from different sources across the medical device landscape, including clinical registries, electronic health records, and medical billing claims,” wrote Laura Marquart, MD, and colleagues from the FDA Center for Devices and Radiological Health in Silver Spring, MD.

“The FDA anticipates exponential growth in knowledge about actual clinical use of specific devices through NEST, which will more efficiently generate evidence for, and decrease the time and cost of, medical device evaluation,” the editorial continued. “Concurrently, the FDA is seeking ways to enhance the robustness of available clinical evidence through the development and coordination of registries.”

Both Ezaldein and co-authors and Marquart and co-authors reported having no relevant conflicts of interest.

2018-01-25T13:00:00-0500

Tagged with:

About author

Related Articles